116
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis

      research-article
      1 , 2 , 1 , 1 , 1 , 2 , 2 , 3 , 4 , 4 , 5 , 5 , 6 , 7 , 7 , 8 , 8 , 9 , 9 , 9 , 10 , 11 , 12 , 12 , 12 , 11 , 13 , 13 , 14 , 15 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 21 , 22 , 22 , 23 , 24 , 1 , * , on behalf of the WHO Working Group for Risk Factors for Severe H1N1pdm Infection
      PLoS Medicine
      Public Library of Science

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study analyzes data from 19 countries (from April 2009 to Jan 2010), comprising some 70,000 hospitalized patients with severe H1N1 infection, to reveal risk factors for severe pandemic influenza, which include chronic illness, cardiac disease, chronic respiratory disease, and diabetes.

          Abstract

          Background

          Since the start of the 2009 influenza A pandemic (H1N1pdm), the World Health Organization and its member states have gathered information to characterize the clinical severity of H1N1pdm infection and to assist policy makers to determine risk groups for targeted control measures.

          Methods and Findings

          Data were collected on approximately 70,000 laboratory-confirmed hospitalized H1N1pdm patients, 9,700 patients admitted to intensive care units (ICUs), and 2,500 deaths reported between 1 April 2009 and 1 January 2010 from 19 countries or administrative regions—Argentina, Australia, Canada, Chile, China, France, Germany, Hong Kong SAR, Japan, Madagascar, Mexico, the Netherlands, New Zealand, Singapore, South Africa, Spain, Thailand, the United States, and the United Kingdom—to characterize and compare the distribution of risk factors among H1N1pdm patients at three levels of severity: hospitalizations, ICU admissions, and deaths. The median age of patients increased with severity of disease. The highest per capita risk of hospitalization was among patients <5 y and 5–14 y (relative risk [RR] = 3.3 and 3.2, respectively, compared to the general population), whereas the highest risk of death per capita was in the age groups 50–64 y and ≥65 y (RR = 1.5 and 1.6, respectively, compared to the general population). Similarly, the ratio of H1N1pdm deaths to hospitalizations increased with age and was the highest in the ≥65-y-old age group, indicating that while infection rates have been observed to be very low in the oldest age group, risk of death in those over the age of 64 y who became infected was higher than in younger groups. The proportion of H1N1pdm patients with one or more reported chronic conditions increased with severity (median = 31.1%, 52.3%, and 61.8% of hospitalized, ICU-admitted, and fatal H1N1pdm cases, respectively). With the exception of the risk factors asthma, pregnancy, and obesity, the proportion of patients with each risk factor increased with severity level. For all levels of severity, pregnant women in their third trimester consistently accounted for the majority of the total of pregnant women. Our findings suggest that morbid obesity might be a risk factor for ICU admission and fatal outcome (RR = 36.3).

          Conclusions

          Our results demonstrate that risk factors for severe H1N1pdm infection are similar to those for seasonal influenza, with some notable differences, such as younger age groups and obesity, and reinforce the need to identify and protect groups at highest risk of severe outcomes.

          Please see later in the article for the Editors' Summary

          Editors' Summary

          Background

          In April 2009, a new strain of influenza A H1N1 was first identified in Mexico and the United States and subsequently spread around the world. In June 2009, the World Health Organization (WHO) declared a pandemic alert phase 6, which continued until August 2010. Throughout the pandemic, WHO and member states gathered information to characterize the patterns of risk associated with the new influenza A H1N1 virus infection and to assess the clinical picture. Although risk factors for severe disease following seasonal influenza infection have been well documented in many countries (for example, pregnancy; chronic medical conditions such as pulmonary, cardiovascular, renal, hepatic, neuromuscular, hematologic, and metabolic disorders; some cognitive conditions; and immunodeficiency), risk factors for severe disease following infection early in the 2009 H1N1 pandemic were largely unknown.

          Why Was This Study Done?

          Many countries have recently reported data on the association between severe H1N1 influenza and a variety of underlying risk factors, but because these data are presented in different formats, making direct comparisons across countries is difficult, with no clear consensus for some conditions. Therefore, to assess the frequency and distribution of known and new potential risk factors for severe H1N1 infection, this study was conducted to collect data (from 1 April 2009 to 1 January 2010) from surveillance programs of the Ministries of Health or National Public Health Institutes in 19 countries―Argentina, Australia, Canada, Chile, China, France, Germany, Hong Kong (special administrative region), Japan, Madagascar, Mexico, the Netherlands, New Zealand, Singapore, South Africa, Spain, Thailand, the United States, and the United Kingdom.

          What Did the Researchers Do and Find?

          As part of routine surveillance, countries were asked to provide risk factor data on laboratory-confirmed H1N1 in patients who were admitted to hospital, admitted to the intensive care unit (ICU), or had died because of their infection, using a standardized format. The researchers grouped potential risk conditions into four categories: age, chronic medical illnesses, pregnancy (by trimester), and other conditions that were not previously considered as risk conditions for severe influenza outcomes, such as obesity. For each risk factor (except pregnancy), the researchers calculated the percentage of each group of patients using the total number of cases reported in each severity category (hospitalization, admission to ICU, and death). To evaluate the risk associated with pregnancy, the researchers used the ratio of pregnant women to all women of childbearing age (age 15–49 years) at each level of severity to describe the differences between levels.

          The researchers were able to collect data on approximately 70,000 patients requiring hospitalization, 9,700 patients admitted to the ICU, and 2,500 patients who died from H1N1 infection. The proportion of patients with H1N1 with one or more reported chronic conditions increased with severity—the median was 31.1% of hospitalized patients, 52.3% of patients admitted to the ICU, and 61.8% of patients who died. For all levels of severity, pregnant women in their third trimester consistently accounted for the majority of the total of pregnant women. The proportion of patients with obesity increased with increasing disease severity—median of 6% of hospitalized patients, 11.3% of patients admitted to the ICU, and 12.0% of all deaths from H1N1.

          What Do These Findings Mean?

          These findings show that risk factors for severe H1N1 infection are similar to those for seasonal influenza, with some notable differences: a substantial proportion of people with severe and fatal cases of H1N1 had pre-existing chronic illness, which indicates that the presence of chronic illness increases the likelihood of death. Cardiac disease, chronic respiratory disease, and diabetes are important risk factors for severe disease that will be especially relevant for countries with high rates of these illnesses. Approximately 2/3 of hospitalized people and 40% of people who died from H1N1 infection did not have any identified pre-existing chronic illness, but this study was not able to comprehensively assess how many of these cases had other risk factors, such as pregnancy, obesity, smoking, and alcohol misuse. Because of large differences between countries, the role of risk factors such as obesity and pregnancy need further study—although there is sufficient evidence to support vaccination and early intervention for pregnant women. Overall, the findings of this study reinforce the need to identify and target high-risk groups for interventions such as immunization, early medical advice, and use of antiviral medications.

          Additional Information

          Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.1001053.

          Related collections

          Most cited references68

          • Record: found
          • Abstract: found
          • Article: not found

          Critically Ill patients with 2009 influenza A(H1N1) in Mexico.

          In March 2009, novel 2009 influenza A(H1N1) was first reported in the southwestern United States and Mexico. The population and health care system in Mexico City experienced the first and greatest early burden of critical illness. To describe baseline characteristics, treatment, and outcomes of consecutive critically ill patients in Mexico hospitals that treated the majority of such patients with confirmed, probable, or suspected 2009 influenza A(H1N1). Observational study of 58 critically ill patients with 2009 influenza A(H1N1) at 6 hospitals between March 24 and June 1, 2009. Demographic data, symptoms, comorbid conditions, illness progression, treatments, and clinical outcomes were collected using a piloted case report form. The primary outcome measure was mortality. Secondary outcomes included rate of 2009 influenza (A)H1N1-related critical illness and mechanical ventilation as well as intensive care unit (ICU) and hospital length of stay. Critical illness occurred in 58 of 899 patients (6.5%) admitted to the hospital with confirmed, probable, or suspected 2009 influenza (A)H1N1. Patients were young (median, 44.0 [range, 10-83] years); all presented with fever and all but 1 with respiratory symptoms. Few patients had comorbid respiratory disorders, but 21 (36%) were obese. Time from hospital to ICU admission was short (median, 1 day [interquartile range {IQR}, 0-3 days]), and all patients but 2 received mechanical ventilation for severe acute respiratory distress syndrome and refractory hypoxemia (median day 1 ratio of Pao(2) to fraction of inspired oxygen, 83 [IQR, 59-145] mm Hg). By 60 days, 24 patients had died (41.4%; 95% confidence interval, 28.9%-55.0%). Patients who died had greater initial severity of illness, worse hypoxemia, higher creatine kinase levels, higher creatinine levels, and ongoing organ dysfunction. After adjusting for a reduced opportunity of patients dying early to receive neuraminidase inhibitors, neuraminidase inhibitor treatment (vs no treatment) was associated with improved survival (odds ratio, 8.5; 95% confidence interval, 1.2-62.8). Critical illness from 2009 influenza A(H1N1) in Mexico occurred in young individuals, was associated with severe acute respiratory distress syndrome and shock, and had a high case-fatality rate.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic.

            The influenza pandemic of 1918-20 is recognized as having generally taken place in three waves, starting in the northern spring and summer of 1918. This pattern of three waves, however, was not universal: in some locations influenza seems to have persisted into or returned in 1920. The recorded statistics of influenza morbidity and mortality are likely to be a significant understatement. Limitations of these data can include nonregistration, missing records, misdiagnosis, and nonmedical certification, and may also vary greatly between locations. Further research has seen the consistent upward revision of the estimated global mortality of the pandemic, which a 1920s calculation put in the vicinity of 21.5 million. A 1991 paper revised the mortality as being in the range 24.7-39.3 million. This paper suggests that it was of the order of 50 million. However, it must be acknowledged that even this vast figure may be substantially lower than the real toll, perhaps as much as 100 percent understated.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women.

              This study sought to quantify influenza-related serious morbidity in pregnant women, as measured by hospitalizations for or death from selected acute cardiopulmonary conditions during predefined influenza seasons. The study population included women aged 15-44 years who were enrolled in the Tennessee Medicaid program for at least 180 days between 1974 and 1993. In a nested case-control study, 4,369 women with a first study event during influenza season were compared with 21,845 population controls. The odds ratios associated with study events increased from 1.44 (95% confidence interval (CI) 0.97-2.15) for women at 14-20 weeks' gestation to 4.67 (95% CI 3.42-6.39) for those at 37-42 weeks in comparison with postpartum women. A retrospective cohort analysis, which controlled for risk factors identified in the case-control study, identified 22,824 study events during 1,393,166 women-years of follow-up. Women in their third trimester without other identified risk factors for influenza morbidity had an event rate of 21.7 per 10,000 women-months during influenza season. Approximately half of this morbidity, 10.5 (95% CI 6.7-14.3) events per 10,000 women-months, was attributable to influenza. Influenza-attributable risks in comparable nonpregnant and postpartum women were 1.91 (95% CI 1.51-2.31) and 1.16 (95% CI -0.09 to 2.42) per 10,000 women-months, respectively. The data suggest that, out of every 10,000 women in their third trimester without other identified risk factors who experience an average influenza season of 2.5 months, 25 will be hospitalized with influenza-related morbidity.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                PLoS Med
                PLoS
                plosmed
                PLoS Medicine
                Public Library of Science (San Francisco, USA )
                1549-1277
                1549-1676
                July 2011
                July 2011
                5 July 2011
                : 8
                : 7
                : e1001053
                Affiliations
                [1 ]Global Influenza Programme, World Health Organization
                [2 ]Medical Research Council Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom
                [3 ]Ministerio de Salud de la Nación, Buenos Aires, Argentina
                [4 ]Influenza Surveillance Section, Surveillance Branch, Office of Health Protection, Department of Health and Ageing, Woden, Australia
                [5 ]Influenza Surveillance Section, Public Health Agency of Canada, Ontario, Canada
                [6 ]Departamento de Epidemiología, División de Planificación Sanitaria, Ministerio de Salud de Chile, Santiago, Chile
                [7 ]Office for Disease Control and Emergency Response, Chinese Center for Disease Control and Prevention Beijing, China
                [8 ]Surveillance and Epidemiology Branch, Centre for Health Protection, Centre for Health Protection of Department of Health, Hong Kong
                [9 ]Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
                [10 ]Département des Maladies Infectieuses, Institut de Veille, Sanitaire, Saint-Maurice Cedex, France
                [11 ]Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Tokyo, Japan
                [12 ]Ministry of Health, Labour and Welfare, Tokyo, Japan
                [13 ]Virology Unit, Institut Pasteur from Madagascar, Antananarivo, Madagascar
                [14 ]Directorate General of Epidemiology, Mexico City, Mexico
                [15 ]Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
                [16 ]New Zealand Ministry of Health, Wellington, New Zealand
                [17 ]Communicable Diseases Division at the Ministry of Health, Singapore
                [18 ]Biodefence Centre, Ministry of Defence, Singapore
                [19 ]Department of Epidemiology and Public Health, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
                [20 ]Epidemiology and Surveillance Unit, Respiratory Virus Unit, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa
                [21 ]Coordinating Centre for Health Alerts and Emergencies, Dirección General de Salud Pública y Sanidad Exterior Ministerio de Sanidad y Política Social, Madrid, Spain
                [22 ]Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand
                [23 ]Health Protection Agency, London, United Kingdom
                [24 ]Epidemiology and Prevention Branch, Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
                The University of Hong Kong, Hong Kong
                Author notes

                Conceived and designed the experiments: AWM MDVK KAHV VS GJG. Analyzed the data: MDVK KAHV VS GJG AWM CAD AK. Wrote the paper: MDVK KAHV VS GJG AWM. ICMJE criteria for authorship read and met: MDVK KAHV VS GJG LOC RO LP JV CG YH FZ SKC AA SB GK WH IB KT KN TS YT TS JMH AO EP MABV LW DH JC VJL JT PSO MJS WH JKU RP SJ AWM CAD AK. Agree with the manuscript's results and conclusions: MDVK KAHV VS GJG LOC RO LP JV CG YH FZ SKC AA SB GK WH IB KT KN TS YT TS JMH AO EP MABV LW DH JC VJL JT PSO MJS WH JKU RP SJ AWM CAD AK. Wrote the first draft of the paper: MDVK KAHV VS GJG AWM. Reviewed and edited several versions of the manuscript: LOC RO LP JV CG YH FZ SKC AA SB GK WH IB KT KN TS YT TS JMH AO EP MABV LW DH JC VJL JT PSO MJS WH JKU RP SJ.

                Article
                PMEDICINE-D-10-00373
                10.1371/journal.pmed.1001053
                3130021
                21750667
                7ddb99ef-fd3a-4ba5-a8cb-bd9eab554688
                This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
                History
                : 27 October 2010
                : 18 May 2011
                Page count
                Pages: 12
                Categories
                Research Article
                Medicine
                Global Health
                Infectious Diseases
                Viral Diseases
                Influenza
                Public Health

                Medicine
                Medicine

                Comments

                Comment on this article

                scite_

                Similar content55

                Cited by286

                Most referenced authors2,237